Characterization of host response to Cryptococcus neoformans through quantitative proteomic analysis of cryptococcal

Lakshmi Dhevi N Selvan1, Sreelakshmi K Sreenivasamurthy, Satwant Kumar

  • 1Institute of Bioinformatics, International Technology Park, Bangalore 560066, India. keshav@ibioinformatics.org.

Molecular Biosystems
|July 17, 2015
PubMed

Insights

This study reveals key host proteins involved in cryptococcal meningitis pathogenesis in HIV patients. Understanding these proteins, like HLA-B and caveolin 1, aids in developing targeted therapies for this severe fungal infection.

Area of Science:

  • Neuroscience
  • Mycology
  • Immunology

Background:

  • Cryptococcal meningitis is a leading cause of death in HIV-associated immunocompromised individuals.
  • Molecular mechanisms of human brain infection by Cryptococcus neoformans remain poorly understood.
  • Limited research exists on host protein involvement in human brain cryptococcal meningitis.

Purpose of the Study:

  • To identify host proteins associated with cryptococcal meningitis pathogenesis in the human brain.
  • To investigate the molecular mechanisms of fungal invasion and infection in the human brain.

Main Methods:

  • Mass spectrometry-based quantitative proteomics was performed on frontal lobe brain tissues from patients with cryptococcal meningitis and controls.
  • Differential protein expression analysis identified significant changes in host proteins.
  • Immunohistochemistry was used to validate the expression status of key identified proteins.

Main Results:

  • 317 out of 3423 human proteins showed differential expression (≥2-fold) in cryptococcal meningitis.
  • Proteins involved in immune response and signal transduction were significantly altered.
  • Upregulation of HLA-B, ACTA2, and CAV1, and downregulation of PMP2 and CRYAB were confirmed.

Conclusions:

  • This study provides the first comprehensive brain proteome profile for HIV-associated cryptococcal meningitis.
  • Identified proteins offer insights into host responses and potential therapeutic targets for cryptococcal meningitis.
  • Understanding these host-pathogen interactions is crucial for improving outcomes in immunocompromised patients.

Related Concept Videos